AXNX - Axonics Inc
IEX Last Trade
69.14
0.040 0.058%
Share volume: 282,822
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$69.10
0.04
0.06%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-09 | 2023-03-01 | 2023-05-02 | 2023-07-31 | 2023-10-31 | 2024-02-29 | 2024-04-30 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 632.278 M | 659.353 M | 665.691 M | 648.985 M | 660.747 M | 719.923 M | 715.561 M | 747.337 M | |
| Current Assets | 449.361 M | 465.075 M | 469.671 M | 455.396 M | 475.385 M | 491.422 M | 482.030 M | 512.063 M | |
| Inventories | 57.827 M | 55.765 M | 66.067 M | 70.083 M | 74.909 M | 79.940 M | 93.187 M | 105.428 M | |
| Other Current Assets | 4.561 M | 7.282 M | 6.342 M | 6.361 M | 6.816 M | 9.279 M | 5.508 M | 6.003 M | |
| Short Term Investments | 4.561 M | 7.282 M | 6.342 M | 6.361 M | 6.816 M | 9.279 M | 5.508 M | 6.003 M | |
| Total Receivables | 36.960 M | 44.817 M | 40.200 M | 47.436 M | 48.944 M | 57.243 M | 50.529 M | 57.221 M | |
| Current Cash | 350.013 M | 357.211 M | 357.062 M | 331.516 M | 344.716 M | 344.960 M | 332.806 M | 343.411 M | |
| Total Non-current Assets | 182.917 M | 194.278 M | 196.020 M | 193.589 M | 185.362 M | 228.501 M | 233.531 M | 235.274 M | |
| Property Plant Equipment | 7.103 M | 6.798 M | 7.017 M | 6.349 M | 6.556 M | 10.760 M | 17.037 M | 18.382 M | |
| Other Assets | 7.085 M | 6.813 M | 6.534 M | 2.817 M | 3.245 M | 24.235 M | 23.703 M | 23.183 M | |
| Intangible Assets | 81.787 M | 86.253 M | 85.888 M | 85.543 M | 80.274 M | 81.375 M | 78.422 M | 76.333 M | |
| Goodwill | 86.942 M | 94.414 M | 96.581 M | 98.880 M | 95.287 M | 99.417 M | 98.543 M | 98.747 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 632.278 M | 659.353 M | 665.691 M | 648.985 M | 660.747 M | 719.923 M | 715.561 M | 747.337 M | |
| Total liabilities | 82.760 M | 89.214 M | 89.085 M | 48.456 M | 50.127 M | 82.359 M | 88.462 M | 104.021 M | |
| Total current liabilities | 60.843 M | 65.247 M | 66.170 M | 32.084 M | 35.593 M | 45.816 M | 48.387 M | 57.173 M | |
| Accounts Payable | 9.972 M | 9.070 M | 14.737 M | 12.185 M | 14.666 M | 18.452 M | 15.770 M | 19.316 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 1.523 M | 1.562 M | 1.557 M | 1.769 M | 1.971 M | 1.777 M | 1.456 M | 2.022 M | |
| Long term debt | 7.960 M | 7.555 M | 7.178 M | 1.199 M | 876.000 K | 25.840 M | 30.154 M | 30.431 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 549.518 M | 570.139 M | 576.606 M | 600.529 M | 610.620 M | 637.564 M | 627.099 M | 643.316 M | |
| Common stock | 47.208 M | 49.080 M | 48.579 M | 49.088 M | 49.245 M | 49.413 M | 50.928 M | 50.010 M | |
| Retained earnings | -374.929 M | -374.264 M | -383.512 M | -390.854 M | -386.926 M | -380.352 M | -399.464 M | -392.565 M |